InMode (InMode) Institutional Ownership

: 32.95% (As of Today)

View and export this data going back to 2019. Start your Free Trial

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, InMode's institutional ownership is 32.95%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, InMode's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, InMode's Float Percentage Of Total Shares Outstanding is 93.39%.

InMode Institutional Ownership Historical Data

The historical data trend for InMode's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Historical Data

The historical data trend for InMode can be seen below:

	2023-06-30	2023-07-31	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31
Institutional Ownership	33.29	34.37	35.16	36.13	32.24	34.17	34.88	35.11	32.93	32.95

InMode Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

InMode (InMode) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

154:Germany 154:Germany

Address

Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206

Website

https://www.inmodemd.com

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.